Skip to content

ADVANTA SLIDER GDS 22114Recalls & reported problems

Atrium Medical Corporation · 4-6MMX45CM, SW, SH, ADVANTA VXT, GDS · Class 2 · Implant

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
11
Deaths reported
0
Injuries reported
4
Recalls naming it
1

Summary

The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 00650862221145), received between Dec 3, 2018 and Dec 27, 2024 — classified as 4 injuries, 7 malfunctions.

The most frequently reported specific device problem is “Material Separation” (3 reports).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 4 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520264
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. May 3, 2024Open, Classified

    Complaints of reported separation of the Slider GDS Swivel Rod from the Swivel Core and of a notable gap between the two pieces.

    Z-1993-2024 · Root cause: Equipment maintenance · FDA record ↗

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Material Separation3
  • Contamination /Decontamination Problem1
  • Leak/Splash1
  • Material Frayed1
  • Material Split, Cut or Torn1
  • Material Twisted/Bent1

Patient problems

  • No Clinical Signs, Symptoms or Conditions5
  • Inflammation1
  • Insufficient Information1
  • No Information1
  • No Known Impact Or Consequence To Patient1
  • Rupture1
  • Tissue Damage1

Recent adverse event reports

The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 27, 2024Material Twisted/Bent; Material Twisted/Bent

    DURING THE AVG PROCEDURE, WHILE CONNECTING THE GRAFT GDS TO THE TUNNELER FOR THE GRAFT DEPLOYMENT PROCESS, SEVERE TWISTING OF THE GRAFT BODY OCCURRED. THE GRAFT WAS REMOVED, AND THE SURGERY WAS COMPLETED USING A CONSIGNED PRODUCT OF THE SAME MODEL (SN (B)(6)). IT APPEARS THAT DURING THE PROCESS OF CONNECTING THE GDS TO THE TUNNELER, NOT ONLY THE GDS BUT ALSO THE GRAFT ROTATED TOGETHER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21024205 ↗
  • MalfunctionJan 19, 2024Material Separation; Material Separation

    N/A.

    Patient problems: Insufficient Information

    MAUDE report 18548387 ↗
  • InjuryJan 18, 2024Material Separation; Material Separation

    DURING AN AVG SURGERY THE VXT GRAFT (22114) TUNNELING PROCESS, A LOT OF GDS CAME OUT AND TISSUE WAS BURIED, SO THE GRAFT WAS REMOVED AND THE SURGERY WAS COMPLETED WITH A NEW VXT GRAFT (22114). HOWEVER, EVEN WITH THE NEW GRAFT, A LOT OF THE GDS TIP CAME OUT. THE PATIENT WHO UNDERWENT SURGERY WITH THE NEW GRAFT IS CURRENTLY DOING WELL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18539770 ↗
  • InjuryJan 8, 2024Material Separation; Material Separation

    DURING AVG SURGERY TUNNELING PROCESS, A LOT OF GDS CAME OUT (MORE TISSUE ACCUMULATES BETWEEN GRAFT AND GDS WHEN THE TUNNELER AND GDS ARE CONNECTED), THE GDS TIP CAME OUT. AND TISSUE WAS BURIED, SO THE GRAFT WAS REMOVED AND THE SURGERY WAS COMPLETED WITH A NEW PRODUCT. THERE WAS A 40 MINS. DELAY IN SURGERY HOWEVER, PATIENT WHO UNDERWENT SURGERY WITH THE NEW PRODUCT ARE CURRENTLY DOING WELL, NO PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18467550 ↗
  • MalfunctionJan 8, 2024Leak/Splash; Leak/Splash

    N/A

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18467538 ↗
  • MalfunctionFeb 22, 2022Material Frayed; Material Frayed

    REPORT RECEIVED STATED THAT DURING THE ARTERIOVENOUS GRAFT (AVG) OPERATION, EPTFE STANDS ADHERED TO THE HELIX UPON REMOVAL. THE OPERATION WAS PERFORMED WITH THE SAME MODEL GRAFT AND THERE WAS NO PROBLEM OR DELAY IN THE OPERATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13581735 ↗
  • InjuryOct 27, 2020Adverse Event Without Identified Device or Use Problem

    N/A.

    Patient problems: Rupture

    MAUDE report 10744890 ↗
  • MalfunctionFeb 11, 2020Material Split, Cut or Torn

    DURING ARTERIOVENOUS GRAFT SURGERY, GRAFT WAS TORN.

    Patient problems: Tissue Damage

    MAUDE report 9697040 ↗
  • MalfunctionSep 16, 2019Adverse Event Without Identified Device or Use Problem

    N/A.

    Patient problems: No Information

    MAUDE report 9072346 ↗
  • InjuryAug 20, 2019Adverse Event Without Identified Device or Use Problem

    AFTER GRAFT TRANSPLANTATION, THERE WAS INFLAMMATION. THE USER ASSUMED THAT THE PROBLEM OCCURRED ELSEWHERE RATHER THAN THE GRAFT PROBLEM.

    Patient problems: Inflammation

    MAUDE report 8910258 ↗
  • MalfunctionDec 3, 2018Contamination /Decontamination Problem

    N/A.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8127370 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.